This study addresses the question, whether quantitative cerebrovascular reactivity (CVR) is a potential vascular biomarker in dementia with Alzheimer’s and vascular pathologies. This was tested in a cross-sectional study, where CBF-CVR assessed via Phase-Contrast-MRI during a CO2 breathing-challenge predicted cognitive and functional performance, disease-severity, and diabetes-risk, in 67 normal and mild-cognitive-impairment subjects. The performance and severity relationships remained robust after adjusting for Alzheimer’s disease and competing vascular markers. These findings suggest that quantitative CBF-CVR has potential as a sensitive biomarker for early changes in cognitive and functional performance, and of disease severity in dementia, independent of Alzheimer’s disease.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords